Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). White skeletal formula on dark teal gradient background with hexagonal pattern. | |
Licence : | Libre de droits |
Crédit: | Science Photo Library / Molekuul |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : | - |